Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 1999
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin
M Jeyakumar, T D Butters, M Cortina-Borja, et al.
Analytical Biochemistry
|
November 10, 2001
High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide
D R Wing, B Garner, V Hunnam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 1999
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents
N Zitzmann, A S Mehta, S Carrouée, et al.
Journal of Virology
|
September 1, 1995
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding
P B Fischer, M Collin, G B Karlsson, et al.
Blood
|
January 3, 2001
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
M Jeyakumar, F Norflus, C J Tifft, et al.
Science (New York, N.Y.)
|
April 18, 1997
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin
F M Platt, G R Neises, G Reinkensmeier, et al.
Journal of Inherited Metabolic Disease
|
December 27, 2006
Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment
T Heare, N J Alp, D A Priestman, et al.
Bioorganic & Medicinal Chemistry
|
April 16, 2013
Novel imino sugar α-glucosidase inhibitors as antiviral compounds
J D Howe, N Smith, M J-R Lee, et al.
Organic & Biomolecular Chemistry
|
October 14, 2016
Structural essentials for β-N-acetylhexosaminidase inhibition by amides of prolines, pipecolic and azetidine carboxylic acids
A F G Glawar, R F Martínez, B J Ayers, et al.
Brain : a Journal of Neurology
|
March 5, 2003
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis
M Jeyakumar, R Thomas, E Elliot-Smith, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 1999
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin
M Jeyakumar, T D Butters, M Cortina-Borja, et al.
Analytical Biochemistry
|
November 10, 2001
High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide
D R Wing, B Garner, V Hunnam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 1999
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents
N Zitzmann, A S Mehta, S Carrouée, et al.
Journal of Virology
|
September 1, 1995
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding
P B Fischer, M Collin, G B Karlsson, et al.
Blood
|
January 3, 2001
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
M Jeyakumar, F Norflus, C J Tifft, et al.
Science (New York, N.Y.)
|
April 18, 1997
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin
F M Platt, G R Neises, G Reinkensmeier, et al.
Journal of Inherited Metabolic Disease
|
December 27, 2006
Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment
T Heare, N J Alp, D A Priestman, et al.
Bioorganic & Medicinal Chemistry
|
April 16, 2013
Novel imino sugar α-glucosidase inhibitors as antiviral compounds
J D Howe, N Smith, M J-R Lee, et al.
Organic & Biomolecular Chemistry
|
October 14, 2016
Structural essentials for β-N-acetylhexosaminidase inhibition by amides of prolines, pipecolic and azetidine carboxylic acids
A F G Glawar, R F Martínez, B J Ayers, et al.
Brain : a Journal of Neurology
|
March 5, 2003
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis
M Jeyakumar, R Thomas, E Elliot-Smith, et al.
Page
of 6